News · 26 weeks37+33%
2025-12-282026-06-21
Mix1090d
- Insider5(50%)
- Other3(30%)
- SEC Filings1(10%)
- Market1(10%)
Latest news
25 items- PRLife Sciences Virtual Investor Forum Agenda Announced for June 24th & 25thNEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings
- PRPetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24thMINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced that John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 24th, 2026 DATE: June 24th TIME: 12:00pm ET REGISTER HERE Available for 1x1 meetings: June 24, 2026, through June 30, 2026. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online
- PRPetVivo Holdings, Inc. to Host Virtual Investor EventVirtual investor event scheduled for Tuesday, June 16, 2026, at 1 p.m. ET MINNEAPOLIS, MN, US, June 08, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, announced today that it will host a virtual investor event titled "What Veterinarians Are Seeing and How Access Is Expanding" on Tuesday, June 16 at 1 p.m. ET. The event is designed for both new and current investors and will provide an overview of the Company's business, including discussion around Spryng® with
- INSIDERLarge owner A.L. Sarroff Fund, Llc gifted 200,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERLarge owner A.L. Sarroff Fund, Llc bought $100,000 worth of shares (250,000 units at $0.40) (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 66,421 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 66,421 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- NEWSPTOP's AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise ClientThis Installation of Tier 1 AI Marks Ninth Deployment and Third Enterprise Customer CAMBRIDGE, MA / ACCESS Newswire / April 29, 2026 / Peer To Peer Network ("PTOP") today announced that it's technology partner Tier 1 AI, has signed Petvivo Holding Inc, Stock Ticker OTCQX:PETV as a client to deploy the Tier 1 AI investor intelligence solution across the company's digital ecosystem. This contract underscores the real demand for AI platform management by executive teams to advance investor marketing, site visitor identification, list segmentation, and the utilization of engagement tools which in combination, do not exist anywhere else in the industry.Under the terms of the agreement, Peer to
- INSIDERSEC Form 4 filed by Rudelius Robert James4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERSEC Form 4 filed by A.L. Sarroff Fund, Llc4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Rudelius Robert James4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Ruben Joshua David4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Levitan Diane M4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Jasper Joseph William4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Costantino Robert J4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERLarge owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 72,282 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 71,993 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECSEC Form 10-Q filed by PetVivo Holdings Inc.10-Q - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTC ID: PETVW)), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported financial and operational results for the third quarter and first nine months of its fiscal year 2026 ended December 31, 2025. The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer session (see dial-in information below). Fiscal Q3 Operational Highlights Signed an exclusive 10-ye
- PRPetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., in collaboration with its wholly-owned subsidiary PetVivo Animal Health (OTCQX:PETV, OTCID: PETVW)), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, today announced that it is retracting and replacing its previously issued press release dated February 9, 2026 regarding the Company's fiscal third quarter 2026 conference call. This press release supersedes in its entirety the prior press release, which should no longer be relied upon. PetVivo will hold a conference call on Tuesday, February 17, 2026, at 5:00 p.m. Eastern Time to discuss resul
- PRPetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX:PETV, OTCID: PETVW)), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Monday, February 16, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal third quarter ended December 31, 2025. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal Third Quarter 2026 conference call information is as follows: Date: Mond
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
PETV FAQ
6 questionsWhat does PetVivo Holdings Inc. do?
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.Where does PETV stock trade?
PetVivo Holdings Inc. (PETV) is listed on NASDAQ.What sector and industry is PETV in?
PetVivo Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about PETV?
PetVivo Holdings Inc. has had 1 recent analyst action on file. The most recent action was from ThinkEquity: Buy with a $700.00 price target on 2021-10-12. Recent price targets cluster around $700.00.What companies are similar to PETV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare PETV side-by-side with any of them on Quantisnow.How can I track PETV on Quantisnow?
Quantisnow aggregates PetVivo Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETV to receive live email and push alerts on every new disclosure.